Clinical Trials

Condition:   Respiratory Syncytial Virus Infections
Interventions:   Drug: ALS-008176 (250 mg);   Drug: ALS-008176 (500 mg);   Drug: ALS-008176 (750 mg);   Other: Placebo
Sponsor:   Janssen Pharmaceutical K.K.
Completed - verified July 2016

Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: Q-Cells
Sponsor:   Q Therapeutics, Inc.
Not yet recruiting - verified October 2016

Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: Albumin
Sponsor:   Instituto Grifols, S.A.
Completed - verified June 2016

Conditions:   Spinal Cord Injury (SCI);   Amyotrophic Lateral Sclerosis (ALS)
Interventions:   Device: Transcranial magnetic stimulation;   Device: Median nerve stimulation;   Device: Cervical transcutaneous stimulation
Sponsor:   Bronx VA Medical Center
Recruiting - verified February 2017

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: ODM-109;   Drug: Placebo for ODM-109
Sponsor:   Orion Corporation, Orion Pharma
Active, not recruiting - verified August 2016

Condition:   EWINGS SARCOMA
Interventions:   Drug: Rabbit anti-thymocyte globulin;   Drug: Busulfan;   Drug: Melphalan;   Drug: Fludarabine;   Drug: Cyclophosphamide
Sponsor:   University of Louisville
Completed - verified December 2016

Conditions:   ALS;   Amyotrophic Lateral Sclerosis;   Lou Gehrig's Disease;   Motor Neuron Disease
Interventions:   Drug: Tocilizumab;   Other: Placebo
Sponsors:   Barrow Neurological Institute;   ALS Association;   Barrow Neurological Foundation;   Massachusetts General Hospital;   Genentech, Inc.
Recruiting - verified December 2016

Conditions:   Kidney Transplant;   Type 1 Diabetes
Interventions:   Drug: Alpha 1-Antitrypsin;   Procedure: Islet Transplantation;   Drug: Thymoglobulin;   Drug: Basiliximab;   Drug: Etanercept
Sponsors:   Massachusetts General Hospital;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of Iowa
Not yet recruiting - verified October 2016

Conditions:   Aplastic Anemia;   Hypoplastic Myelodysplastic Syndrome
Interventions:   Drug: BL-8040;   Drug: horse anti-thymocyte globulin (hATG);   Drug: Methylprednisolone;   Drug: Cyclosporine
Sponsor:   BioLineRx, Ltd.
Recruiting - verified June 2016

Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Drug: EPI-589
Sponsor:   Edison Pharmaceuticals Inc
Recruiting - verified July 2016